|
September 2010 |
Features
Lessons Learned From the ACCORD Eye Study
Better glycemic control and therapy of dyslipidemia can forestall progression of diabetic retinopathy in patients with type 2 diabetes
siRNA: Set for a Comeback?
By: Rita Ehrlich, MD; Thomas A. Ciulla, MD
Although small-interfering RNA drugs faltered in recent trials, their potential merits continue to inspire research
Improving Wound Construction Techniques for MIVS
By: Peter K. Kaiser, M.D.
Expert advice on avoiding complications
Clinical Management of Systemic Inflammatory Diseases Affecting the Posterior Segment
By: Thomas E. Flynn, MD; Gale A. McCarty, MD, FACP, FACR
Part 2 of this article explores Susac’s syndrome, Wegener’s granulomatosis, polyarteritis nodosa and Takayasu’s arteritis
Disposable vs Reusable Surgical Instruments: How to Decide?
By: Maggie F. Shuler, MD, PhD; Alan Franklin, MD, PhD; John P. Myers, MD; Sunil Gupta, MD
Which instruments should you choose based on cost and procedure?
Nonarteritic Anterior Ischemic Optic Neuropathy
By: Omar S. Punjabi, MD; Angelo P. Tanna, MD; Michael A. Rosenberg, MD
Its clinical features, diagnosis and treatment
Conservative Treatment of Ciliary Body Melanoma With Extraocular Extension
By: Emily Kolbus; Carlos Bianciotto, MD; Carol L. Shields, M.D.
Plaque radiotherapy allowed this patient to avoid enucleation
Comparing Intravitreal Injection Protocols and Practices
By: Kirk H. Packo, MD, FACS; David S. Dyer, MD; Thomas R. Friberg, MD; Baruch D. Kupperman, MD, PhD; Michael Tolentino, MD
An expert roundtable on clinical decision-making and the nuances of technique
Departments
Upfront
By: Jason S. Slakter, M.D.
From the editor-in-chief
Subspecialty News
By: Jerry Helzner, Senior Editor
Lucentis in vitrectomized eyes; A safer way to treat eye cancer; Ozurdex/anti-VEGF therapy in wet AMD
Innovation in Retina
By: Pravin U. Dugel, MD; Emmett T. Cunningham, Jr., MD, PhD, MPH
A “Tipping Point” for Retina R&D: Implications and Expectations
Controversies in Care
By: Michael Colucciello, MD; Steve Charles, MD, FACS, FICS; John Thompson, MD
The role of indocyanine green in macular hole surgery
Coding Q&A
By: Riva Lee Asbell
Cataract combined with vitreoretinal surgery